DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Phase 2

Recruiting

Conditions: Borderline Personality Disorder
Major Depressive Disorder

Interventions: Drug: Psilocybin

First Posted Date: 2022-06-01

Last Posted Date: 2025-03-05

Lead Sponsor: University of Chicago

Target Recruit Count: 10

Registration Number: NCT05399498

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Reintegration of Children From Institutions in Azerbaijan

Not Applicable

Active, not recruiting

Conditions: Child Mental Disorder
Emotional Trauma
Child Maltreatment

Interventions: Behavioral: Usual Care
Behavioral: Family Strengthening
Behavioral: Mental Health Screening, Referral and Connection to Services
Other: Economic Empowerment

First Posted Date: 2022-05-31

Last Posted Date: 2025-01-01

Lead Sponsor: University of Chicago

Target Recruit Count: 400

Registration Number: NCT05396625

Locations: 🇦🇿
National Mental Health Centre under the Ministry of Health, Republic of Azerbaijan, Baku, Azerbaijan
🇦🇿
Research and Education Center, Baku, Azerbaijan

Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function

Early Phase 1

Completed

Conditions: Social Behavior
Motivation
Stimulant Use
MDMA ('Ecstasy')

Interventions: Drug: MDMA
Drug: Methamphetamine
Drug: placebo oral tablet

First Posted Date: 2022-05-18

Last Posted Date: 2024-01-24

Lead Sponsor: University of Chicago

Target Recruit Count: 43

Registration Number: NCT05379959

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Caplyta in Borderline Personality Disorder

Phase 2

Recruiting

Conditions: Borderline Personality Disorder

Interventions: Drug: Placebo
Drug: Caplyta

First Posted Date: 2022-05-02

Last Posted Date: 2025-05-02

Lead Sponsor: University of Chicago

Target Recruit Count: 60

Registration Number: NCT05356013

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Antidepressant Effects of Nitrous Oxide

Phase 2

Recruiting

Conditions: Treatment Resistant Depression
Major Depressive Disorder

Interventions: Drug: Nitrous oxide gas for inhalation
Drug: Placebo

First Posted Date: 2022-05-02

Last Posted Date: 2024-12-04

Lead Sponsor: University of Chicago

Target Recruit Count: 172

Registration Number: NCT05357040

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia

GI Oxalate Absorption

Not Applicable

Recruiting

Conditions: Kidney Stone
Bariatric Surgery Candidate

Interventions: Other: Special low-oxalate diet followed by all-day visit to University of Chicago research clinic

First Posted Date: 2022-05-02

Last Posted Date: 2024-05-24

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT05356000

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Nitrous Oxide as Treatment for Fibromyalgia

Phase 2

Recruiting

Conditions: Fibromyalgia
Central Neuropathic Pain

Interventions: Drug: Placebo
Drug: Nitrous oxide gas for inhalation

First Posted Date: 2022-05-02

Last Posted Date: 2024-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 50

Registration Number: NCT05357066

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery

Phase 4

Recruiting

Conditions: Pain, Postoperative

Interventions: Other: Placebo
Drug: Morphine Sulfate

First Posted Date: 2022-04-28

Last Posted Date: 2025-01-09

Lead Sponsor: University of Chicago

Target Recruit Count: 90

Registration Number: NCT05351229

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Phase 4

Terminated

Conditions: Acute Decompensated Heart Failure

Interventions: Drug: SGLT2i
Other: No SGLT2i

First Posted Date: 2022-04-26

Last Posted Date: 2023-12-06

Lead Sponsor: University of Chicago

Target Recruit Count: 1

Registration Number: NCT05346653

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Novel Desensitization Kidney Transplantation

Phase 1

Recruiting

Conditions: Kidney Transplantation
End Stage Kidney Disease (ESRD)

Interventions: Drug: Belatacept Injection

First Posted Date: 2022-04-26

Last Posted Date: 2024-06-04

Lead Sponsor: University of Chicago

Target Recruit Count: 5

Registration Number: NCT05345717

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy